Asim Kumar Debnath

This inventor holds 21 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Antiviral Compounds. Top assignees: New York Blood Center, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1998-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Asim Kumar Debnath. Retrieved from https://idiyas.com/inventor/asim-kumar-debnath

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 6)

% Patents Active = 85.7

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 129(Granted Patents)

Location History:

New York, NY (US) (1998 - 2016)
Fort Lee, NJ (US) (1999 - 2023)

Company Filing History:

21 out of 194

New York Blood Center, Inc.

patents

6 out of 3,696

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

where one patent can have more than one assignee

Years Active: 1998-2023

Loading Chart...

Areas of Expertise:

Antiviral Peptides

HIV Inhibitors

Small Molecule Inhibitors

Therapeutic Activity

Retroviral Assembly

Viral Infections

HIV Entry

Screening Compounds

Phenylpyrrolecarboxamides

HIV-1

HIV-2

Core Structure

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11571409 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV (2023-02-07),

2. 11059808 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV (2021-07-13),

3. 10869856 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV (2020-12-22),

4. 10576059 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV (2020-03-03),

5. 10413527 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV (2019-09-17),

6. 10137107 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV (2018-11-27),

7. 9309237 - HIV inhibitors (2016-04-12),

8. 8940864 - Stabilized therapeutic small helical antiviral peptides (2015-01-27),

9. 8937154 - Stabilized therapeutic small helical antiviral peptides (2015-01-20),

10. 8933019 - Antiviral cell-penetrating peptides (2015-01-13),

11. 8546439 - Small molecule inhibitors of retroviral assembly and maturation (2013-10-01),

12. 8324153 - Antiviral cell-penetrating peptides (2012-12-04),

13. 8299093 - Small molecule inhibitors of retroviral assembly and maturation (2012-10-30),

14. 7241803 - Compounds for inhibition of HIV infection by blocking HIV entry (2007-07-10),

15. 6727240 - Methods for preventing HIV-1 or HIV-2 infection (2004-04-27),

Title: The Inventor Extraordinaire: Asim Kumar Debnath

Introduction:

Asim Kumar Debnath is a notable inventor based in Fort Lee, NJ, with a prolific career in patenting innovations. With a total of 21 patents to his name, Debnath has made significant contributions to the field of HIV treatment with his groundbreaking inventions.

Latest Patents:

Debnath's latest patents revolve around the development of substituted phenylpyrrolecarboxamides with therapeutic activity in HIV. These compounds, as represented by Formula A, have shown immense potential in the treatment of HIV infection and related conditions, highlighting Debnath's dedication to advancing medical solutions.

Career Highlights:

Throughout his career, Debnath has worked with reputable organizations such as the New York Blood Center, Inc., and The United States of America, represented by the Department of Health and Human Services. His expertise and innovative mindset have been instrumental in driving forward advancements in the healthcare industry, particularly in the fight against HIV.

Collaborations:

Debnath has collaborated with esteemed professionals in the field, including Francesca Curreli and Shibo Jiang. Together, they have collectively worked towards developing novel solutions and pushing the boundaries of scientific research in the realm of HIV treatment.

Conclusion:

In conclusion, Asim Kumar Debnath stands as a pioneering inventor whose relentless pursuit of innovation has led to groundbreaking developments in the field of HIV therapeutics. His impressive portfolio of patents underscores his commitment to making a tangible impact on society through his revolutionary inventions.

Profile summary based on public USPTO records.